Dieting Disorders in Depth
Body Image
A person's body image is
their perception of their physical appearance. It is more than what a person thinks they will see in a mirror,
but is inextricably tied to their self-esteem and acceptance by peers. A person with a poor body image will
perceive their own body as being unattractive or even repulsive to others.
While a person with good body image, or positive "body acceptance," will
either see themselves as attractive to others, or will at least accept it as is. Body image is most strongly
affected during puberty, and is influenced by peers, parents, teachers and mentors, and commercial
advertising (i.e. Barbie dolls).
In the United States, poor body image is widespread, especially (but not
exclusively) among women, and often leads to a variety of eating disorders, including anorexia nervosa,
bulimia, and binge eating disorder. Other possible effects of the cultural obsession with looking thin may
include binge exercising, fad diets, and multiple cases of suing fast food chains.
Body dysmorphic disorders cover a range of personality disorders
where a person is dissatisfied with one's own body. When a person is dissatisfied with their own body, they
often resort to drastic measures to alter it and, most often, this takes the form of eating
disorders or cosmetic surgery. At this site, we are going to discuss the most common
forms of eating disorders, in particular, Anorexia Nervosa, Bulima and Binge Eating
Disorder.
Anorectics
Anorectics, anorexigenics or appetite suppressants, are substances which
reduce the desire to eat ("anorectic," from the Greek an = "not" and oreg = "extend,
reach").
Used on a short term basis clinically to treat obesity, some appetite
suppressants are also available over the counter. Drugs of this class are frequently stimulants of the
phenethylamine family, related to amphetamine (speed). Indeed, amphetamine itself was sold commercially as an
appetite suppressant until it was outlawed in most parts of the world in the late 1950s due to increasing
exploitation of its stimulant properties ("abuse"). Many amphetamines produce side effects including
addiction, tachycardia and hypertension, making prolonged unsupervised use dangerous.
Epidemics of fatal pulmonary hypertension and heart valve damage associated
with anorectic agents have led to the withdrawal of products from the market. This was the case with aminorex
in the 1960s, and again in the 1990s with fenfluramine (see: Fen-phen). Likewise, association of the related
appetite suppressant phenylpropanolamine with hemorrhagic stroke led the FDA to request its withdrawal from
the market in the United States in 2000, and similar concerns regarding ephedrine resulted in an FDA ban on
its inclusion in dietary supplements, in 2004.
In spite of these precedents, numerous related compounds are still marketed
today as appetite suppressants. These include phentermine (Fastin®, Adipex®, Ionamin® and others),
diethylpropion (Tenuate®), phendimetrazine (Prelu-2®), benzphetamine (Didrex®) and others. Sibutramine
(Medaria®, Reductil®) is a recent addition, which is used with orlistat by doctors to control obesity. The
new cannabinoid receptor antagonist Rimonabant (Acomplia®) will be available in 2006.
Anorexia Nervosa
Anorexia nervosa (commonly shortened to anorexia) is an eating disorder
characterised by voluntary starvation and exercise stress. Anorexia nervosa is a complex disease, involving
psychological, sociological and physiological components. A person who is suffering from anorexia is known as
an anorectic (although the spellings anorexic and anoretic also exist).
Anorexia also refers to loss of appetite, usually considered as a medical
symptom.
Clinical definition of Anorexia
The following is considered the "textbook" definition of anorexia nervosa to
assist doctors in making a clinical diagnosis. It is in no way representative of what a sufferer feels or
experiences in living with the illness. It is important to note that an individual can still suffer from
anorexia even if one of the below signs is not present. In other words, it is dangerous to read the
diagnostic criteria and think either oneself or others must not be anorectic because one or more of the
symptoms listed are not present.
-
Refusal to maintain body weight at or above a minimally normal weight
for age and height (e.g., weight loss leading to maintenance of body weight less than 85% of that
expected; or failure to make expected weight gain during period of growth, leading to body weight
less than 85% of that expected).
-
Maintaining excessive physical activity.
-
Intense fear of gaining weight or becoming fat, even though
underweight.
-
Disturbance in the way in which one's body weight or shape is
experienced, undue influence of body weight or shape on self-evaluation, or denial of the seriousness
of the current low body weight.
-
In postmenarcheal females (women who have not yet gone through
menopause), amenorrhea (the absence of at least three consecutive menstrual
cycles).
Restricting Type: during the current episode of anorexia nervosa, the
person has not regularly engaged in binge-eating or purging behavior (i.e. self-induced vomiting or the
misuse of laxatives, diuretics, or enemas)
Binge-Eating Type or Purging Type: during the current episode of
anorexia nervosa, the person has regularly engaged in binge-eating OR purging behavior (i.e., self-induced
vomiting or the misuse of laxatives, diuretics, or enemas).
Click here to
learn more about Anorexia
Nervosa.

|